- Report
- April 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,781GBP
- Report
- April 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,781GBP
- Report
- April 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,781GBP
- Report
- April 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,781GBP
- Report
- March 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,781GBP
- Report
- March 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,781GBP
- Report
- October 2023
- 115 Pages
Global
From €4017EUR$4,500USD£3,438GBP
- Report
- April 2026
- 85 Pages
From €4241EUR$4,750USD£3,629GBP
- Report
- February 2024
- 100 Pages
Asia Pacific
From €4241EUR$4,750USD£3,629GBP
- Report
- February 2024
- 110 Pages
Global
From €4241EUR$4,750USD£3,629GBP
- Report
- April 2023
- 100 Pages
Latin America
From €4241EUR$4,750USD£3,629GBP
- Report
- April 2023
- 115 Pages
Global
From €4241EUR$4,750USD£3,629GBP
- Report
- April 2023
- 75 Pages
Europe
From €4241EUR$4,750USD£3,629GBP
- Report
- June 2022
- 114 Pages
Global
From €4241EUR$4,750USD£3,629GBP
- Report
- November 2024
- 202 Pages
Global
From €2232EUR$2,500USD£1,910GBP
- Report
- October 2024
- 136 Pages
Global
From €2232EUR$2,500USD£1,910GBP
- Report
- January 2026
- 195 Pages
India
From €2232EUR$2,500USD£1,910GBP
- Report
- August 2025
- 224 Pages
Global
From €2232EUR$2,500USD£1,910GBP
- Report
- June 2025
- 198 Pages
Global
From €2232EUR$2,500USD£1,910GBP
- Report
- June 2025
- 214 Pages
Global
From €2232EUR$2,500USD£1,910GBP

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more